Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ANAB

AnaptysBio

$75.70

2.14 (2.91%)

06:59
04/03/19
04/03
06:59
04/03/19
06:59
Recommendations
AnaptysBio analyst commentary at Stifel »

AnaptysBio could have 45%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANAB

AnaptysBio

$70.38

-0.85 (-1.19%)

09:55
03/25/19
03/25
09:55
03/25/19
09:55
Conference/Events
AnaptysBio participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

ANAB

AnaptysBio

$71.23

-4.16 (-5.52%)

04:55
03/25/19
03/25
04:55
03/25/19
04:55
Conference/Events
AnaptysBio participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

Over a month ago
ANAB

AnaptysBio

$74.48

2.55 (3.55%)

11:35
03/18/19
03/18
11:35
03/18/19
11:35
Conference/Events
AnaptysBio participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

ANAB

AnaptysBio

$71.18

5.26 (7.98%)

, REGN

Regeneron

$415.32

3.22 (0.78%)

11:50
03/12/19
03/12
11:50
03/12/19
11:50
Recommendations
AnaptysBio jumps after JPMorgan surveys doctors on asthma data »

Shares of AnaptysBio…

ANAB

AnaptysBio

$71.18

5.26 (7.98%)

REGN

Regeneron

$415.32

3.22 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

ACRS

Aclaris Therapeutics

$6.62

-0.2 (-2.93%)

, DERM

Dermira

$9.05

-0.2 (-2.16%)

08:29
03/06/19
03/06
08:29
03/06/19
08:29
Conference/Events
Cantor Fitzgerald pharma analysts to hold an analyst/industry conference call »

Pharmaceuticals Analysts…

ACRS

Aclaris Therapeutics

$6.62

-0.2 (-2.93%)

DERM

Dermira

$9.05

-0.2 (-2.16%)

LLY

Eli Lilly

$128.45

0.99 (0.78%)

PFE

Pfizer

$42.89

-0.2 (-0.46%)

REGN

Regeneron

$437.68

3.5 (0.81%)

INCY

Incyte

$85.11

-0.29 (-0.34%)

ANAB

AnaptysBio

$68.82

-1.89 (-2.67%)

GLPG

Galapagos NV

$101.58

-1.14 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 12

    Mar

  • 28

    Apr

  • 13

    May

  • 18

    May

  • 24

    May

ANAB

AnaptysBio

$71.65

1.62 (2.31%)

06:00
02/28/19
02/28
06:00
02/28/19
06:00
Hot Stocks
AnaptysBio says cash will fund operating plan at least through end of 2020 »

AnaptysBio said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANAB

AnaptysBio

$71.65

1.62 (2.31%)

05:58
02/28/19
02/28
05:58
02/28/19
05:58
Earnings
Breaking Earnings news story on AnaptysBio »

AnaptysBio reports Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANAB

AnaptysBio

$64.87

-0.12 (-0.18%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
AnaptysBio initiated at Guggenheim »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ANAB

AnaptysBio

$72.74

1.16 (1.62%)

08:15
01/18/19
01/18
08:15
01/18/19
08:15
Recommendations
AnaptysBio analyst commentary at SunTrust »

AnaptysBio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.